# Tamoxifen to Treat Barrett's Metaplasia

> **NCT02089386** · EARLY_PHASE1 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 7 (actual)

## Conditions studied

- Barrett Metaplasia

## Interventions

- **DRUG:** Tamoxifen
- **PROCEDURE:** Endoscopy

## Key facts

- **NCT ID:** NCT02089386
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07-09
- **Primary completion:** 2016-06-21
- **Final completion:** 2016-06-21
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Insufficient funding
- **Last updated:** 2017-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02089386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02089386, "Tamoxifen to Treat Barrett's Metaplasia". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02089386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*